Clean Label Supplements Exceed US Food And Drug Administration Requirements For Purity
Dendera is dedicated to the practice of 100 percent natural ingredients in each of their products. No synthetic materials are...
Year: 2021
Hospital Asset Management Market Escalates amid Deepening Smart Technology Penetration: Fact.MR
Monotony and tediousness associated with manual record keeping is compelling hospitals to invest in automated tracking solutions, leading to a...
SunTech Medical and Valencell Announce Proof of Concept for DeltaTrak(TM) Blood Pressure, a Major Advancement in BP Technology
MORRISVILLE, NC / ACCESSWIRE / February 8, 2021 / SunTech Medical Inc., the leading provider of clinical-grade blood pressure (BP)...
ATEC to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
CARLSBAD, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions...
OZSC: Ozop Energy Systems Announces New Director of Operations
WARWICK, N.Y., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. (OZSC), (“Ozop” or the “Company”), is pleased to announce the...
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
ROCKVILLE, Md., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
Glen Rock, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company” or “we”),...
Castellum, Inc. Announces Hiring of Glen Ives to Build Navy and Marine Corps Division of Company
Castellum, Inc. Announces Hiring of Glen Ives to Build Navy and Marine Corps Division of Company Mr. Glen Ives has...
Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer’s Disease
AUSTIN, Texas, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates...
Predictive Oncology’s Wholly Owned Subsidiary Helomics announces the start of its drug repurposing project using its ground-breaking PeDAL™ platform for ovarian cancer
MINNEAPOLIS, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”)...
Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants
LA JOLLA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing...
Entera Bio Initiates New Research Program For Oral GLP-2
‒ Program Leverages Entera’s Platform for Potential Development of Oral GLP-2 Analogs for Gastrointestinal and Other Indications ‒‒ GLP-2 Analogs...
AzurRx BioPharma to Present at BIO CEO & Investor Digital Conference
DELRAY BEACH, Fla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company...
Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories for DMT Preclinical Studies
VANCOUVER, British Columbia, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer
CAMBRIDGE, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer
Cindy Collins to Step Down Effective February 15, 2021 James C. Mullen Editas Medicine announces the appointment of James C....
Learning to Prevent the Next Pandemic: VaxHunt Game Earns STEM.org Educational Trustmark
The Influenzer Initiative’s online game earns the STEM.org Authenticated™ Educational Product Trustmark VaxHunt: The Quest to Prevent the Next Pandemic...
Sigilon Therapeutics Announces Preclinical Data in Multiple Lysosomal Diseases at the 17th Annual WORLDSymposium™
Results demonstrate potential of Company’s therapies developed using its novel Shielded Living Therapeutics™ platform to treat broad range of chronic diseasesCAMBRIDGE,...
Clubhouse Media Group Closes Acquisition of Magiclytics
LOS ANGELES, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS: CMGR) (“Clubhouse Media” or...
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
WALTHAM, Mass. and HALLE (Saale), Germany, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused...